Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Reese Pharmaceutical Company

Reese Pharmaceutical Company Recalls

All product recalls associated with Reese Pharmaceutical Company.

Get alerts for this brand

Recall Summary

Total Recalls

597

Past Year

Class I (Serious)

Most Recent

May 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 261–280 of 597 recalls

Immune Support Tablets (Reese) – Unlisted Sodium (2017)

The label does not list "Sodium" in the ingredient statement.

Class IIModerate

FDAAug 31, 2017AL, AZ, AR +37 more• Reese Pharmaceutical Company

Sterile Products (Vital Rx) - Sterility Concerns (2017)

Lack of Assurance of Sterility .

Class IIModerate

FDAAug 17, 2017Nationwide• Vital Rx, Inc. dba Atlantic Pharmacy and Compounding

Tri Mix Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class II

1...12 131415 16...30

Page 14 of 30Next

Moderate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Pyridoxal-5-Phos Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Progesterone Sesame Oil Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

PGE1/Procaine Injection (Key Pharmacy) – Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Vitamin B Complex Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Ferrous Gluconate Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Atropine Sulfate Ophthalmic (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

DMSO Ophthalmic Solution (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Magnesium Sulfate Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Hydroxocobalamin Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

GSH/NAC Inhalation Solution (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

GSH/NAC Inhalation Solution (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

TRI MIX Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

PGE1 Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center